Видео ютуба по тегу Menin Inhibition

Ravi Vij, in Discussion with Dr. Suresh Balasubramanian M.D, On Menin Inhibitors in Treatment of AML
Ravi Vij, in Discussion with Dr. Suresh Balasubramanian M.D, On Menin Inhibitors in Treatment of AML
Ravi Vij, in Discussion with Dr. Suresh Balasubramanian M.D, On Menin Inhibitors in Treatment of AML
Ravi Vij, in Discussion with Dr. Suresh Balasubramanian M.D, On Menin Inhibitors in Treatment of AML
Leukemia ASH 2024 Highlights - Menin Inhibitors, CPX 351 vs 7+3, Venetoclax Based Regimens
Leukemia ASH 2024 Highlights - Menin Inhibitors, CPX 351 vs 7+3, Venetoclax Based Regimens
The Evolving Role of Menin Inhibitors in Acute Leukemias
The Evolving Role of Menin Inhibitors in Acute Leukemias
Epigenetics Podcast #139 - Menin-MLL Complex & Small Molecule Inhibitors with Yadira Soto-Feliciano
Epigenetics Podcast #139 - Menin-MLL Complex & Small Molecule Inhibitors with Yadira Soto-Feliciano
Updates on menin inhibitors for acute leukemia and the pushback of revumenib approval
Updates on menin inhibitors for acute leukemia and the pushback of revumenib approval
Potential for Menin inhibitors with R/R AML Highlighting the KOMET-001 Clinical Trial
Potential for Menin inhibitors with R/R AML Highlighting the KOMET-001 Clinical Trial
Advancements in menin inhibitors for acute leukemias: insights from EHA 2024
Advancements in menin inhibitors for acute leukemias: insights from EHA 2024
Menin inhibitors in AML: mechanism of action, the current key data, and predicting efficacy
Menin inhibitors in AML: mechanism of action, the current key data, and predicting efficacy
Immunophenotypic changes induced by menin inhibition in AML
Immunophenotypic changes induced by menin inhibition in AML
Targeted therapies in AML: menin, FLT3 and IDH inhibitors
Targeted therapies in AML: menin, FLT3 and IDH inhibitors
Promising novel agents in AML: menin inhibitors
Promising novel agents in AML: menin inhibitors
A Phase I trial of DSP-5336, a novel menin inhibitor, in the treatment of AML
A Phase I trial of DSP-5336, a novel menin inhibitor, in the treatment of AML
First-in-human study of the menin-KMT2A inhibitor JNJ-75276617 in R/R acute leukemias
First-in-human study of the menin-KMT2A inhibitor JNJ-75276617 in R/R acute leukemias
Menin inhibition in diabetes: clinical trials with BMF-219
Menin inhibition in diabetes: clinical trials with BMF-219
Phase I trial of the menin inhibitor JNJ-75276617 in patients with acute leukemia
Phase I trial of the menin inhibitor JNJ-75276617 in patients with acute leukemia
COVALENT-101: investigating menin inhibition with BMF-219 for treating patients with R/R AML or ALL
COVALENT-101: investigating menin inhibition with BMF-219 for treating patients with R/R AML or ALL
Hot topics in the AML space: menin inhibitors
Hot topics in the AML space: menin inhibitors
Preclinical Research of Menin Inhibitor for Chronic Lymphocytic Leukemia (CLL) - ASCO 2022
Preclinical Research of Menin Inhibitor for Chronic Lymphocytic Leukemia (CLL) - ASCO 2022